Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Aptadel Therapeutics Logo
Aptadel Therapeutics Growth Score
92
CB Rank
45613
Heat Score
52
Aptadel Therapeutics is a pre-clinical biomedical company.
Founded
obfuscation
PrivateSeed Barcelona, Catalonia, Spain1-10 www.aptadeltx.com
Biotechnology
Health Care
Overview

Aptadel Therapeutics
Total Funding
obfuscation
Growth Score
92
Heat Score
52

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score92
5 pts
in past quarter
Heat Score 52
11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Aptadel Therapeutics

CB Rank
45613
Aptadel Therapeutics is a pre-clinical biomedical company.
Founded
obfuscation
PrivateSeed Barcelona, Catalonia, Spain1-10 www.aptadeltx.com
Biotechnology
Health Care

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name APTADEL THERAPEUTICS SL.
Operating Status Active
Company Type For Profit
Founders  Gisela Lorente, Oscar Martinez Tirado
About the Company
Aptadel Therapeutics is a pre-clinical biomedical company focused on developing an RNA-based platform of targeted therapy delivery to treat cancer.
Predictions & Insights

Growth Insight

See this Growth Insight
Aptadel Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

ADEL-101
A preclinical drug targeting Ewing Sarcoma, a pediatric cancer, using RNA aptamer technology for specific tumor targeting.
ADEL-102
A preclinical drug aimed at treating Rhabdomyosarcoma, utilizing RNA aptamer technology for enhanced drug delivery to tumor cells.

Research & Development

Aptadel Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Aptadel Therapeutics Logo
Seed Round - Aptadel Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Aptadel Therapeutics Logo
Seed Round - Aptadel Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Aptadel Therapeutics Logo
Seed Round - Aptadel Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Aptadel Therapeutics Logo
Seed Round - Aptadel Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Aptadel Therapeutics Logo
Seed Round - Aptadel Therapeutics
2
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Aptadel Therapeutics Logo
Seed Round - Aptadel Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Aptadel Therapeutics Logo
Seed Round - Aptadel Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Aptadel Therapeutics Logo
Seed Round - Aptadel Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Aptadel Therapeutics Logo
Seed Round - Aptadel Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Aptadel Therapeutics Logo
Seed Round - Aptadel Therapeutics
2
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Board Members and Advisors 2 Contacts 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Mar 25, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 24, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 15, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 30, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

333
1,232%
 in past month

IT Spend

$95.9KThis year, Aptadel Therapeutics is projected to spend $95.9K on IT, according to Aberdeen.

Active Website Tech Count

4Aptadel Therapeutics is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, CloudFront, and  SiteGround CAPTCHA.

Total IP

1Aptadel Therapeutics has 1 registered patent in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Aptadel Therapeutics's headquarters? Aptadel Therapeutics is located in Barcelona, Catalonia, Spain.Who invested in Aptadel Therapeutics? Aptadel Therapeutics has 3 investors including Little Warrior Foundation and  Newsight Tech Angels.When was the last funding round for Aptadel Therapeutics? Aptadel Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Aptadel Therapeutics's competitors? Alternatives and possible competitors to Aptadel Therapeutics may include Sarepta Therapeutics and  Refaccionaria Moderna.How much funding has Aptadel Therapeutics raised to date? Aptadel Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(baaa708 1)
|